The effect of platelet‐activating factor (PAF) on nasal airway resistance in healthy subjects is not mediated by nitric oxide

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Allergy. European Journal of Allergy and Clinical Immunology

• Publication date

  2000-08-01

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1034/j.1398-9995.2000.00603.xPMID 10955702
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mediator release after nasal airway challenge with allergen.

  2015cited by this paper
• Nasal Nitric Oxide Does Not Control Basal Nasal Patency or Acute Congestion following Allergen Challenge in Allergic Rhinitis

  1999cited by this paper
• Relationship between nasal nitric oxide concentration and nasal airway resistance.

  1997cited by this paper
• Nasal nitric oxide is increased in patients with asthma and allergic rhinitis and may be modulated by nasal glucocorticoids.

  1997cited by this paper
• Effect of a nasal challenge with endotoxin-containing swine confinement dust on nasal nitric oxide production.

  1997cited by this paper
• Differential activity of nitric oxide synthase in human nasal mucosa and polyps.

  1996influential reference
• Attenuation of human nasal airway responses to bradykinin and histamine by inhibitors of nitric oxide synthase

  1996influential reference
• Measurement of nitric oxide in human nasal airway.

  1996cited by this paper
• High nitric oxide production in human paranasal sinuses

  1995cited by this paper
• Nitric oxide metabolites in nasal lavage fluid of patients with house dust mite allergy.

  1995cited by this paper
• Platelet activating factor modulates microvascular permeability through nitric oxide synthesis.

  1995cited by this paper
• Exhaled nitric oxide in isolated pig lungs.

  1995cited by this paper
• The nose and the lower airways.

  1994cited by this paper
• Nasal neutrophilia and eosinophilia induced by challenge with platelet activating factor.

  1994cited by this paper
• Autoinhalation of nitric oxide after endogenous synthesis in nasopharynx.

  1994cited by this paper
• Vasodilator and constrictor actions of platelet-activating factor in the isolated microperfused afferent arteriole of the rabbit kidney. Role of endothelium-derived relaxing factor/nitric oxide and cyclooxygenase products.

  1993cited by this paper
• Induction of nitric oxide synthase in asthma.

  1993cited by this paper
• Effect of an inhibitor of nitric oxide synthase on neural relaxation of human bronchi.

  1993cited by this paper
• Expression and characterization of the heme-binding domain of Chlorella nitrate reductase.

  1993cited by this paper
• Modulation by nitric oxide of platelet‐activating factor‐induced albumin extravasation in the conscious rat

  1993cited by this paper
• Study of the effects of paf‐acether on human nasal airways

  1991cited by this paper
• Castleman's disease of the mediastinum: misleading clinical and radiological characteristics.

  1989cited by this paper
• Allergic rhinitis: a rational choice of treatment.

  1989cited by this paper
• Mediator release after nasal airway challenge with allergen.

  1983cited by this paper
• Kinins are generated in vivo following nasal airway challenge of allergic individuals with allergen.

  1983cited by this paper

• Lysophosphatidylcholine Acyltransferase 2 Contributes to Increased Allergic and Irritant Inflammation in Mice

  2024cites this paper
• Nasal Mucosal Expression of the Receptors for Inflammatory Chemical Mediators.

  2016cites this paper
• Recent Advances on Nitric Oxide in the Upper Airways.

  2016cites this paper
• Short report Open Access

  2015cites this paper
• Using magnetic resonance imaging to quantify the inflammatory response following allergen challenge in allergic rhinitis

  2015cites this paper
• Evaluation of nasal symptoms induced by platelet activating factor, after nasal challenge in both healthy and allergic rhinitis subjects pretreated with rupatadine, levocetirizine or placebo in a cross-over study design

  2013cites this paper
• Microarray analysis of NF-κB-dependent genes in chronic rhinosinusitis with nasal polyps.

  2013cites this paper
• What are the primary clinical symptoms of rhinitis and what causes them?

  2011cites this paper
• Rupatadine 10 mg in adolescent and adult symptom relief of perennial allergic rhinitis

  2010cites this paper
• Reduction of nasal volume after allergen-induced rhinitis in patients treated with rupatadine: a randomized, cross-over, double-blind, placebo-controlled study.

  2009cites this paper
• Nitric oxide in upper airways inflammatory diseases

  2007influential citation
• Nasal nitric oxide and nasal allergy

  2006cites this paper
• HUMMING, NITRIC OXIDE AND PARANASAL SINUS VENTILATION

  2006cites this paper
• Nasal NO measurement by direct sampling from the nose during breathhold: aspiration flow, nasal resistance and reproducibility

  2006cites this paper
• Expression and localization of platelet-activating factor receptor in human nasal mucosa.

  2005cites this paper
• Endothelial nitric oxide synthase/soluble guanylate cyclase system in human nasal polyps

  2005influential citation
• Nitric oxide attenuates platelet‐activating factor‐induced nasal airway plasma extravasation in healthy subjects

  2002cites this paper
• Outcome measures

  2002cites this paper
• Effect of nitric oxide inhibition on nasal airway resistance after nasal allergen challenge in allergic rhinitis

  2001cites this paper